Last updated on December 19th, 2024 at 09:43 pm
Emcure Pharmaceuticals IPO overview! Issue Size, GMP, Issue Price, and All Details to Know Emcure Pharmaceuticals Limited.
About Emcure Pharmaceuticals IPO
Emcure Pharmaceuticals Limited is a vertically integrated pharmaceutical company manufacturing diverse products, including complex injectables, biotherapeutics, and specialty APIs.
Emcure Pharmaceuticals IPO Details
Emcure Pharmaceuticals Pharmaceutical company
Website: – Click Here
- Company: Emcure Pharmaceuticals Limited
- Price Range: ₹960 – ₹1008 per share
- Total Shares: 13,440 shares
- Lot Size: 14 shares per lot
- Start: 3rd July 2024
- End: 5th July 2024
- Allotment: 8th July 2024
- Refund Initiation: 9th July 2024
- Demat Transfer: 9th July 2024
- Listing: 10th July 2024
- Mandate End Date: 20th July 2024
| Employee | Click here |
| Individual investor | Click here |
GMP OF Emcure Pharmaceuticals IPO
Emcure Pharmaceuticals IPO GMP is ₹330 as of today.
| GMP Date | IPO PRICE | GMP |
|---|---|---|
| 04-07-2024 | 1008.00 | ₹330 ⬆️ |
| 03-07-2024 (Open) | 1008.00 | ₹330 ⬆️ |
Summary of Financial Information
| Metric | Amount (in ₹ million) | Insight |
|---|---|---|
| Revenue from Operations | 66,582.51 | Total revenue generated from core business operations. |
| Profit for the Year | 5,275.75 | Net profit after accounting for all expenses, taxes, and costs. |
| Total Borrowings | 20,919.35 | All short-term and long-term borrowings. |
| Net Worth | 29,522.83 | Residual interest in assets after deducting liabilities. |
Promoters
- Satish Ramanlal Mehta
- Sunil Rajanikant Mehta
- Namita Vikas Thapar
- Samit Satish Mehta
| Promoter | Number of Equity Shares | Percentage of Pre-Offer Equity Share Capital (%) |
|---|---|---|
| Satish Ramanlal Mehta | 75,816,748 | 41.85 |
| Sunil Rajanikant Mehta | 2,887,012 | 1.59 |
| Namita Vikas Thapar | 6,339,800 | 3.50 |
| Samit Satish Mehta | 13,547,632 | 7.48 |
| Total | 98,591,192 | 54.42 |
(Emcure Pharmaceuticals …)
Key Points
- Competitive Conditions: Emcure operates in a competitive environment and expects competition to intensify.
- Seasonality: The business is not seasonal in nature.
- Significant Developments: No significant developments after March 31, 2024, materially affecting operations or profitability have been reported, except the subscription to NCDs issued by Avet Life for ₹2,500.00 million
Stock market disclaimer
Note: The information we provide is based on our analysis, do your research before making an investment decision with a stock market disclaimer.
Also Read: – Magenta Lifecare IPO overview! Issue Size, GMP, Issue Price, and All Details to Know.
FAQS Emcure Pharmaceuticals
What is the GMP (Grey Market Premium) of Emcure Pharmaceuticals IPO?
The shares of Emcure Pharmaceuticals IPO are trading at a premium of ₹255 in the grey market premium (GMP).
What is the current share price of Emcure Pharmaceuticals?
As the company is about to list, the current share price in the grey market is at a premium of ₹255 over the issue price band of ₹960 to ₹1008 per share.
When is the Emcure Pharmaceuticals IPO date?
The Emcure Pharmaceuticals IPO opens on July 3, 2024, and closes on July 5, 2024.
What is the Emcure IPO share price?
The price band for the Emcure Pharmaceuticals IPO is set at ₹960 to ₹1008 per share.
What is the GMP (Grey Market Premium) of Emcure Pharmaceuticals IPO?
The GMP for Emcure Pharmaceuticals IPO is ₹255.
What is the valuation of Emcure Pharmaceuticals?
The total IPO size is ₹1952.03 crores, including a fresh issue of ₹800 crores and an offer for sale of ₹1152.03 crores.
When is the Emcure Pharmaceuticals IPO allotment date?
The allotment for Emcure Pharmaceuticals IPO is expected to be finalized on July 8, 2024.
Emcure Pharmaceuticals IPO details in Hindi?
Emcure Pharmaceuticals का IPO 3 जुलाई 2024 को खुलेगा और 5 जुलाई 2024 को बंद होगा। IPO का प्राइस बैंड ₹960 से ₹1008 प्रति शेयर है।
